Russia manufactures 10 basic medicines used as the first line treatment of HIV infection. They are used in the treatment of approximately 60-70% of HIV infected patients. This was reported by Veronika Skvortsova, the Minister of Health of the Russian Federation.
The past decade has seen the establishment of 16 sites to manufacture the medicines used to begin the treatment of people with that disease. This was facilitated by the program of the Ministry of Industry and Trade of the Russian Federation for the development of pharmaceutical industry. As a result, in 2016, the cost of one annual course using the basic treatment scheme was reduced approximately 2-fold, that allowed to increase by 20% the coverage of HIV infected patients with antiretroviral therapy.
At the same time, the Russian scientific community continues its fight against the infection. Currently, the researchers led by Vadim Pokrovsky, the Head of the AIDS Prevention and Control Department at the Central Research Institute of Epidemiology of Rospotrebnadzor, are developing a medicine aimed at introducing special genes into the cell to protect it from the virus of immunodeficiency. The medicine has passed preclinical trials.